ABSTRACT: In October 2004, one of the major producers of the U.S. influenza vaccine supply announced that their vaccine would not be available because of production problems, resulting in approximately half of the anticipated supply suddenly becoming unavailable. This study was part of a larger effort using community-based participatory research (CBPR) principles to distribute influenza vaccine to hard-to-reach populations. Given the extant literature suggesting economic and racial disparities in influenza vaccine access in times of adequate supply and our inability to distribute vaccine due to the shortage, we sought to examine vaccine access as well as awareness of the vaccine shortage and its impact on health-seeking behaviors in eight racially-diverse and economicallydisadvantaged neighborhoods in New York City (NYC) during the shortage. In our study few people had been vaccinated, both among the general community and among high risk groups; vaccination rates for adults in priority groups and non-priority groups were 21.0% and 3.5%. Awareness of the 2004 vaccine shortage was widespread with over 90% being aware of the shortage. While most attributed the shortage to production problems, almost 20% said that it was due to the government not wanting to make the vaccine available. Many respondents said they would be more likely to seek vaccination during the current and subsequent influenza seasons because of the shortage. The target neighborhoods were significantly affected by the national influenza vaccine shortage. This study highlights the challenges of meeting the preventive health care needs of hard-to-reach populations in times of public health crisis.
INTRODUCTION
Influenza is a major public health concern. There were over 61,000 deaths from influenza and pneumonia in the United States in 2004, making these conditions the eighth leading cause of death. 1 During the most recent influenza epidemics in the U.S., it was estimated that up to 220,000 people were hospitalized due to influenza. 2 In October 2004, one of the major producers of the U.S. influenza vaccine supply announced that their vaccine would not be available because of production problems. 3 The effect on the U.S. vaccine supply was unexpected and dramatic, with approximately half of the anticipated supply suddenly becoming unavailable.
A recent study examined influenza vaccination coverage in the U.S. during the 2004-2005 vaccine shortage. 4 According to this study 42% of adults in priority groups (e.g., persons aged ‡ 65 years, health care workers with patient contact, household contacts of children < 6 months of age and persons with one or more of the following conditions: asthma and other lung problems, heart problems, diabetes, kidney problems, weakened immune system anemia and pregnancy) and 8.8% of adults not in a priority group received a vaccination between September 2004 and January 2005.
There are well documented racial/ethnic disparities in influenza immunization rates. A study using data from the 1996 Medical Expenditure Panel Survey compared influenza vaccination levels of different racial/ ethnic groups. 5 Among 2,309 persons aged ‡ 65, Whites had the highest vaccination coverage (68.0%) followed by Hispanics (61.7%), and Blacks (47.3%). Adjustment for potential confounders including health risk, age distribution, health status, family size, ambulatory care visits, and poverty level failed to account for these differences. In terms of socioeconomic status and social disadvantage, characteristics that have been shown to be associated with lower vaccination rates include living in residence owned by someone else, marital status and unemployment.
METHODS
This study was conducted as a part of Project VIVA (Venue-Intensive Vaccination for Adults), which was designed to assess barriers to vaccination in specific communities in East Harlem and the Bronx and to use this research to guide a vaccination intervention in these same neighborhoods. 7 These two communities are among the most socio-economically disadvantaged communities in New York City. Within East Harlem and the South Bronx, our study was carried out in eight small neighborhoods. These neighborhoods are areas of particular disadvantage within the larger communities. They were defined by a process of consultation with community members from East Harlem and the South Bronx.
From January to December 2004, outreach workers had been in the field conducting surveys in an effort to enumerate the target population and provide educational materials about influenza and influenza vaccine. At the time the vaccine shortage was announced, we were gearing up for the distribution of vaccine for Project VIVA, which had been scheduled to begin in early October 2004. Due to the national shortage, we did not receive vaccine and therefore conducted surveys to assess awareness of the shortage and access to the vaccine in our target neighborhoods.
We aimed to recruit hard-to-reach persons (e.g., active injection drug users, sex workers, undocumented immigrants, and elderly shutins) in each of the eight neighborhoods within East Harlem and the Bronx, New York City. Briefly, to recruit subjects we used venue-based sampling specified through community-based collaboration to find locations where hard-to-reach populations congregate. 8 The study was approved by the Institutional Review Board of the New York Academy of Medicine.
From October to December 2004, outreach workers approached potential participants and asked them if they would be willing to complete a brief survey. Those providing oral informed consent were administered a brief, anonymous survey about vaccination history and barriers to vaccination. The survey included questions about sociodemographic characteristics, access to health care, and risk behaviors (e.g. drug use, commercial sex work, etc.). In addition, we included a series of questions related to the vaccine shortage, including knowledge of the shortage, access to the vaccine during the shortage, and attitudes towards Project VIVA in light of the shortage. All people engaged by the outreach workers were offered information about influenza vaccine, including information of where to get it, regardless of their willingness to participate in the survey.
RESULTS
We first examined sociodemographic characteristics of the 272 people interviewed during this study period (data not shown). Most (84.8%) were aged 49 years or younger, 13.3% were aged 50 to 64 and 1.9% were 65 years or older. The population was 75% male and predominately Hispanic (69.6%), followed by Black (23.3%), other (4.1%) and White (3.0%). Most had a total yearly legal income of less than $9600 per year (63.3%). Almost all considered themselves to be stably housed (81.2%), although some were transitionally housed (15.1%) or homeless (3.3%). Almost 13.0% had been hungry in the last 6 months. A small proportion had injected drugs or traded sex in the last six months (3.3% and 3.7%, respectively).
In terms of access to health and social services, 78.5% had some type of health insurance (data not shown). Almost 85% reported having access to routine health care. Among those without routine medical care, the most common reason for not having it was not having enough money. The majority (72%) had an influenza shot at least once in their lifetime, of whom 24.1% were vaccinated in the past year. Table 1 reports knowledge of the vaccine shortage and its affect on health-seeking behaviors. Most (91.1%) were aware of the vaccine shortage, having found out through television (79.0%), the newspaper (34.8%), word-of-mouth (16.6%), and/or a doctor or health care provider (11.7%). Most attributed the shortage to manufacturer production problems (59.5%); 18.9% said the government did not want to make the vaccine available. More than one-quarter (26.9%) said the shortage had changed their mind about getting the influenza vaccine this year, of whom 70.8% said they were now more likely to seek out an influenza shot this year. Slightly fewer (24.4%) said the shortage had changed their mind about getting the influenza vaccine next year, of whom (80.3%) were more likely to try to seek out the influenza shot. In terms of the impact of the shortage on our relationship with the community, 25.7% of respondents said the shortage changed their mind about receiving services from Project VIVA, with 86.6% being more likely to seek out of services.
Overall, 245 (90.1%) people surveyed were medically eligible for an influenza shot. Of those medically eligible, 116 (47.7%) had tried to obtain (21.0%) actually received an influenza shot. Among the 145 in the nonpriority groups 52 (35.9%) tried to get vaccinated and 5 (3.5%) received an influenza shot. There were no significant differences by race in terms of trying to obtain a vaccination; however, those who reported other race were significantly (p = 0.02) more likely to have been vaccinated since October 1, 2004 than Hispanics, Blacks or Whites (40.0% vs. 9.7%, 9.8% and 0%, respectively -data not shown).
DISCUSSION
We found that awareness of the 2004 vaccine shortage was widespread in eight disadvantaged neighborhoods in NYC with over 90% of the population being aware of the shortage. This level of knowledge is consistent with a previous study which reported that 92% of elderly patients surveyed in Pittsburgh were aware of the 2000 influenza vaccine delay. 9 While most recognized that the shortage was due to production problems, almost 20% said that the shortage was due to the government not wanting to make the vaccine available. This finding suggests that issues of trust may be important to consider when bringing interventions to ethnically diverse populations.
Many respondents said they would be more likely to seek influenza vaccination during the current and subsequent influenza seasons because 10 A recent review has suggested that interventions that provide vaccine outside medical settings such as primary and tertiary care are needed. 11 It is unclear why our population was more likely to try to get vaccinated, but it may have been related to outreach efforts we had conducted in the community prior to the influenza season.
In our study few people had been vaccinated, both among the general community and among high risk groups; the vaccination rates for adults in priority groups and non-priority groups were 21.0% and 3.5%, respectively as compared to national estimates of 42% and 8.8%. 4 Thus, compared to estimates from the CDC, overall vaccination rates were lower in this population suggesting that economically-disadvantaged communities would benefit from focused vaccination efforts in times of mass shortage.
The 2004 influenza vaccine shortage resulted in a surprising and dramatic reduction in vaccine supply in the United States. Vaccine supply and distribution in the U.S. is not primarily driven by need, but rather by the costs of research, development, testing and manufacturing and a market that is small compared to other drug products. 12 This situation has led to maldistribution of vaccine, often leaving sicker and/or poorer patients unprotected. 13 In this study, we observed that a group of economically-disadvantaged and ethnically-diverse communities in New York City were significantly affected by the national influenza vaccine shortage. This study highlights the challenges of meeting the preventive health care needs of hard-to-reach populations in times of public health crisis. Further study is needed to determine if such disparities exist for similar communities in times of shortage. Directed and culturally appropriate interventions are needed to address the preventive health care needs of these communities.
